The estimated Net Worth of Lifesciences I, L.P.Clarus ... is at least $511 Миллион dollars as of 8 August 2012. Lifesciences Clarus owns over 804,232 units of Globus Medical Inc stock worth over $501,805,803 and over the last 12 years Lifesciences sold GMED stock worth over $8,975,229.
Lifesciences has made over 1 trades of the Globus Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Lifesciences sold 804,232 units of GMED stock worth $8,975,229 on 8 August 2012.
The largest trade Lifesciences's ever made was selling 804,232 units of Globus Medical Inc stock on 8 August 2012 worth over $8,975,229. On average, Lifesciences trades about 402,116 units every 0 days since 2012. As of 8 August 2012 Lifesciences still owns at least 7,244,201 units of Globus Medical Inc stock.
You can see the complete history of Lifesciences Clarus stock trades at the bottom of the page.
Over the last 12 years, insiders at Globus Medical Inc have traded over $375,265,297 worth of Globus Medical Inc stock and bought 2,005 units worth $99,824 . The most active insiders traders include David C Paul, Kurt Wheeler и David M Demski. On average, Globus Medical Inc executives and independent directors trade stock every 42 days with the average trade being worth of $11,005,133. The most recent stock trade was executed by Leslie V Norwalk on 11 July 2024, trading 1,000 units of GMED stock currently worth $70,000.
globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.
Globus Medical Inc executives and other stock owners filed with the SEC include: